J Kim1. 1. 1] Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, South Korea [2] Research Institute of Medical Nutrition, Kyung Hee University, Seoul, South Korea.
Abstract
BACKGROUND/ OBJECTIVES: This study explored the association between serum 25-hydroxyvitamin D (25(OH)D) or parathyroid hormone (PTH) concentrations and the risk of metabolic syndrome (MetS) in middle-aged and older Korean adults using the most recent, nationally representative survey data. SUBJECTS/ METHODS: The study sample consisted of 2624 Korean adults (⩾ 50 years old) who participated in the fifth Korean National Health and Nutrition Examination Surveys. Serum 25(OH)D was measured by radioimmunoassay and serum PTH was measured using chemiluminescence assay. MetS was defined according to the joint interim statement of the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute. RESULTS: Serum 25(OH)D concentrations were significantly lower in subjects with MetS than in subjects without MetS, and the prevalence of MetS significantly decreased according to quartiles of serum 25(OH)D concentration. Serum 25(OH)D concentrations were negatively associated with the risk of elevated blood pressure (P for trend = 0.039), hypertriglyceridemia (P for trend = 0.0474) and reduced high-density lipoprotein cholesterol (P for trend= 0.0139), whereas serum PTH concentrations were positively associated with the risk of elevated blood pressure (P for trend = 0.0002) after adjusting for age, gender, residential district, education level, income, smoking status, body mass index, alcohol intake and physical activity. Furthermore, serum 25(OH)D concentrations were inversely associated with the risk of MetS after adjusting for confounding factors (P for trend = 0.0163). However, serum PTH concentrations were not associated with the risk of MetS. CONCLUSION: Serum 25(OH)D concentration may be an independent risk factor of MetS among middle-aged and older Korean adults.
BACKGROUND/ OBJECTIVES: This study explored the association between serum 25-hydroxyvitamin D (25(OH)D) or parathyroid hormone (PTH) concentrations and the risk of metabolic syndrome (MetS) in middle-aged and older Korean adults using the most recent, nationally representative survey data. SUBJECTS/ METHODS: The study sample consisted of 2624 Korean adults (⩾ 50 years old) who participated in the fifth Korean National Health and Nutrition Examination Surveys. Serum 25(OH)D was measured by radioimmunoassay and serum PTH was measured using chemiluminescence assay. MetS was defined according to the joint interim statement of the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute. RESULTS: Serum 25(OH)D concentrations were significantly lower in subjects with MetS than in subjects without MetS, and the prevalence of MetS significantly decreased according to quartiles of serum 25(OH)D concentration. Serum 25(OH)D concentrations were negatively associated with the risk of elevated blood pressure (P for trend = 0.039), hypertriglyceridemia (P for trend = 0.0474) and reduced high-density lipoprotein cholesterol (P for trend= 0.0139), whereas serum PTH concentrations were positively associated with the risk of elevated blood pressure (P for trend = 0.0002) after adjusting for age, gender, residential district, education level, income, smoking status, body mass index, alcohol intake and physical activity. Furthermore, serum 25(OH)D concentrations were inversely associated with the risk of MetS after adjusting for confounding factors (P for trend = 0.0163). However, serum PTH concentrations were not associated with the risk of MetS. CONCLUSION: Serum 25(OH)D concentration may be an independent risk factor of MetS among middle-aged and older Korean adults.
Authors: Núria Vilarrasa; Joan Vendrell; Javier Maravall; Iñaki Elío; Esther Solano; Patricia San José; Isabel García; Núria Virgili; Juan Soler; José Manuel Gómez Journal: Endocrine Date: 2010-07-23 Impact factor: 3.633
Authors: Claudia Gagnon; Zhong X Lu; Dianna J Magliano; David W Dunstan; Jonathan E Shaw; Paul Z Zimmet; Ken Sikaris; Peter R Ebeling; Robin M Daly Journal: J Clin Endocrinol Metab Date: 2012-03-22 Impact factor: 5.958
Authors: Jared P Reis; Denise von Mühlen; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor Journal: Diabetes Care Date: 2007-03-10 Impact factor: 19.112
Authors: Armin Zittermann; Sabine Frisch; Heiner K Berthold; Christian Götting; Joachim Kuhn; Knut Kleesiek; Peter Stehle; Heinrich Koertke; Reiner Koerfer Journal: Am J Clin Nutr Date: 2009-03-25 Impact factor: 7.045